| CAS ID: | 346735-24-8 |
| Molecular Formula: | C33H34N2O5 |
| Molecular Weight: | 538.6 g/mol |
| Monoisotopic Mass: | 538.2468 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | LS-49968 | BIIL 284 BS | BIIL 284 | AMELUBANT |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C33H34N2O5/c1-4-38-32(37)35-31(34)25-8-16-29(17-9-25)39-21-23-6-5-7-24(20-23)22-40-30-18-12-27(13-19-30)33(2,3)26-10-14-28(36)15-11-26/h5-20,36H,4,21-22H2,1-3H3,(H2,34,35,37) | See All |
| InChI Key: | SBVYURPQULDJTI-UHFFFAOYSA-N | |
| Smiles: | CCOC(=O)NC(=N)c1ccc(OCc2cccc(COc3ccc(cc3)C(C)(C)c4ccc(O)cc4)c2)cc1 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02269189 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | October 21, 2014 | Last Verified | October 21, 2014 |
| Sponsor | Boehringer Ingelheim | ||
Trial Record 2
| ClinicalTrial ID | NCT02265679 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | October 16, 2014 | Last Verified | October 16, 2014 |
| Sponsor | Boehringer Ingelheim | ||
Trial Record 3
| ClinicalTrial ID | NCT00060801 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | May 14, 2003 | Last Verified | October 31, 2013 |
| Sponsor | Boehringer Ingelheim | ||
| PubChem: | 60096302 |
| ChEMBL: | CHEMBL1742420 |